Renovion
Latest round
- Series A
Last raised
- Jun 2020
Total raised
- $8.1M
Investors
- 2
About Renovion
Renovion, Inc., based in Chapel Hill, US, was founded in 2013 and specializes in lung health therapies.Renovion, Inc. specializes in developing innovative therapies aimed at restoring lung health, particularly for patients suffering from conditions such as lung transplant complications, non-cystic fibrosis bronchiectasis (NCFBE), and chronic bronchitis (CB). Its flagship product, ARINA·1, is designed to enhance mucus clearance in the lungs, addressing significant health challenges faced by patients requiring lung transplantations and those diagnosed with chronic respiratory conditions. Revenue generation is primarily derived from the sale of ARINA·1, as well as potential collaborations with pharmaceutical companies for further development and marketing of new therapies.Renovion, Inc.1 mn to support the development and launch of new products, including enhancements to ARINA·1. The company aims to expand into new markets, particularly targeting regions in Europe and Asia by the end of 2022. This strategic expansion is aimed at increasing accessibility to its lung health therapies and addressing the rising demand for effective treatments in these regions.
Who invested in Renovion
2 investors across 2 rounds
See all investors in Renovion
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Renovion
Who invested in Renovion?
Renovion has 2 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Renovion raised?
Renovion has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Renovion last raise money?
Renovion's most recent round on record is a Series A, in Jun 2020.
What does Renovion do?
Renovion is a biotechnology company.
Where is Renovion headquartered?
Renovion is headquartered in Chapel Hill, US.
Which VCs invest in companies like Renovion?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Renovion's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Renovion? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.